Innovation trajectory of Software as a Medical Device: Evidence from the US FDA-approved products.
PMID: 42389386 ·
Jiakan Yu, Jiajie Zhang, Shuto Miyashita, Shintaro Sengoku
JournalDigital health
Year
PMID42389386
Abstract
Digital health innovation is reshaping healthcare, with Software as a Medical Device (SaMD) as a critical frontier. However, little is known about how enterprises evolve portfolios within this regulated market. This study uses enterprise-level SaMD product portfolio data to characterize innovation trajectories in SaMD development and assess heterogeneity in these trajectories across enterprise characteristics. We identify 578 FDA-approved products from 289 enterprises (2012-2022) using the OpenF
Official Source
View on PubMed →Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.